Your institution may have access to this item. Find your institution then sign in to continue.
Title
Prophylactic oseltamivir treatment for prevention of donor-recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment.
A letter to the editor is presented which discusses a case of a 45-year old Caucasian woman who was treated with prophylactic oseltamivir to prevent viral transmission of the novel influenza (A) H1N1 2009 virus from a donor-recipient.